AAPP has pledged up to $500,000 to the AAPP Foundation to directly support multi-site studies of the impact of psychiatric pharmacists. The first AAPP Outcomes Initiative grant was awarded during AAPP 2024. AAPP continues to work hard to standardize and improve clinical research, and psychiatric pharmacists are encouraged to learn more about the upcoming research grant competition at AAPP 2025!
Stimulants (e.g., methylphenidate and amphetamine salts) are effective medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. This free toolkit is intended to provide an evidence-based guide for thoughtfully converting from one stimulant product formulation to another. The toolkit provides information in the following areas:
A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model established which attributes constitute best practice for OPPs. By developing a consensus for best practice model attributes, outpatient psychiatric pharmacists can work toward consistent, effective patient care.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Facilitating Change to Develop a Practice Position in Psychiatric Pharmacy.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Impact on Team Well-Being.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Job Description Templates.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to Behavioral Health Integration (BHI) Model of Care.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes. This practice expansion toolkit provides background and resources related to "Incident to" Billing.
Psychiatric pharmacists are advanced practice clinical pharmacists who specialize in mental health care. With an extensive knowledge of medication management, they are skilled at treating the whole patient. They strengthen the mental health team by working directly with patients and improving treatment outcomes.
No summary available
The ultimate goal is that every patient with a psychiatric disorder, including substance use disorders, will have their medication therapy reviewed, optimized, and managed by a psychiatric pharmacist as part of a psychotropic stewardship team. In short, intentional efforts to have a Board Certified Psychiatric Pharmacist (BCPP) provide Comprehensive Medication Management (CMM) services to patients with psychiatric disorders will improve access, outcomes, and cost.
AAPP envisions a world where all individuals living with mental illness receive safe, appropriate, and effective treatment. To achieve that, it is important to promote practices that reflect the best current evidence available. Thus, over time, all content will either be updated or removed from the web site.
The COS-PP toolkit is intended to provide guidance and support for research related to psychiatric pharmacist impact. Students, residents, pharmacists, and faculty can use the COS-PP to help design clinical trials. Utilization of a unified core outcome set will ultimately benefit the patients by providing robust evidence of the value of having psychiatric pharmacists on the team to improve access to care, quality of care, and patient satisfaction.